Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

Clinical trial NCT06678074 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06678074
Sponsor: Implicit Bioscience
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

STEMI STEMI (ST Elevation MI)STEMI - ST Elevation Myocardial Infarction (MI)Stent Implantation

Start date: 2025-02-06
Primary completion: 2026-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.